|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 738.34 USD | +6.17% |
|
+13.26% | -4.34% |
| 31/07 | Regeneron Pharmaceuticals Shares Rise After Higher Q2 Results | MT |
| 30/07 | Regeneron Pharmaceuticals, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
| Market Cap | 7.51TCr 6.52TCr 6.06TCr 5.59TCr 11TCr 7,17100Cr 11TCr 72TCr 28TCr 3,56200Cr 28TCr 28TCr 11,97800Cr | P/E 2026 * |
16.7x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 6.89TCr 5.98TCr 5.56TCr 5.13TCr 9.65TCr 6,57800Cr 9.83TCr 66TCr 26TCr 3,26700Cr 26TCr 25TCr 10,98700Cr | EV / Sales 2026 * |
4.1x | EV / Sales 2027 * | 3.58x |
| Free-Float |
72.32% | Yield 2026 * |
0.52% | Yield 2027 * | 0.6% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +6.17% | ||
| 1 week | +13.26% | ||
| Current month | +18.41% | ||
| 1 month | +18.41% | ||
| 3 months | +4.42% | ||
| 6 months | -0.42% | ||
| Current year | -4.34% |
| 1 week | 659.53 |  | 740 |
| 1 month | 625.7 | | 740 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/07/26 | Sell | Director | -200 | 0.0002% | ||
| 19/02/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 09/02/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.17% | +13.26% | +33.13% | -1.04% | 7.51TCr | |
| +3.59% | -8.70% | +17.93% | +178.94% | 4.76TCr | |
| +3.25% | +52.70% | +52.70% | +52.70% | 4.95TCr | |
| -3.81% | +6.32% | -54.61% | -54.17% | 4.29TCr | |
| -0.62% | +3.64% | +64.19% | -21.60% | 3.07TCr | |
| -3.23% | +5.40% | +58.59% | +94.94% | 2.49TCr | |
| +6.29% | +1.58% | +80.16% | -51.19% | 2.3TCr | |
| -1.53% | -3.61% | -11.53% | +150.58% | 1.96TCr | |
| +1.52% | +4.63% | +77.52% | +132.33% | 1.72TCr | |
| -1.68% | -0.95% | +80.05% | +138.64% | 1.61TCr | |
| Average | +0.98% | +2.90% | +39.81% | +62.01% | 3.47TCr | |
| Weighted average by Cap. | +1.85% | +3.86% | +32.52% | +48.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.68TCr 1.46TCr 1.35TCr 1.25TCr 2.35TCr 1,60300Cr 2.4TCr 16TCr 6.28TCr 80TCr 6.31TCr 6.17TCr 2,67800Cr | 1.8TCr 1.57TCr 1.46TCr 1.34TCr 2.53TCr 1,72300Cr 2.57TCr 17TCr 6.75TCr 86TCr 6.78TCr 6.63TCr 2,87800Cr |
| Net income | 464.91Cr 403.82Cr 374.99Cr 345.84Cr 651.44Cr 44TCr 663.24Cr 4.44TCr 1.74TCr 22TCr 1.75TCr 1.71TCr 74TCr | 523.48Cr 454.69Cr 422.24Cr 389.41Cr 733.51Cr 50TCr 746.79Cr 5TCr 1.96TCr 25TCr 1.97TCr 1.92TCr 83TCr |
| Net Debt | -621.57Cr -539.9Cr -501.36Cr -462.38Cr -870.96Cr -59TCr -886.74Cr -5.94TCr -2.32TCr -29TCr -2.33TCr -2.28TCr -99TCr | -1.06TCr -916.7Cr -851.27Cr -785.07Cr -1.48TCr -1,00800Cr -1.51TCr -10TCr -3.95TCr -50TCr -3.96TCr -3.88TCr -1,68300Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $738.34 | +6.17% | 14,60,963 |
| 29/26/29 | $695.42 | +0.03% | 10,22,421 |
| 28/26/28 | $695.18 | +4.20% | 9,00,408 |
| 27/26/27 | $667.17 | +1.70% | 6,50,984 |
| 24/26/24 | $656.01 | +0.63% | 7,08,392 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
